Mater Research Pilot Targets Killer Breast Cancers | AcademicJobs
Mater Research Institute-UQ launches $1.9M pilot targeting aggressive breast cancers like TNBC via CDCP1. Explore the science, impacts, and careers in this higher ed breakthrough.
No reviews yet. Be the first to rate Jodi!
Dr Jodi Saunus is a Senior Research Fellow and Mater Career Track Fellow at Mater Research, affiliated with The University of Queensland. She specialises in translational research on metastatic breast cancer, with a particular emphasis on triple-negative breast cancer and the prevention and treatment of brain metastases. Based at Brisbane’s Translational Research Institute, she was recruited by Mater Research in 2022 to advance patient-focused research bridging biomedical development and clinical practice. Dr Saunus holds an honours degree in biochemistry and biomedical science and a PhD in breast cancer molecular genetics from The University of Queensland. Her postdoctoral experience encompasses immunology, molecular cell biology, pathology informatics, and early-phase investigator-initiated clinical trials.
Her research involves molecular profiling of patient-donated samples to identify biomarkers of treatment response and therapeutic targets, experimental models to understand mechanisms of cancer cell survival in brain tissue, and development of innovative strategies including alpha-particle endoradiotherapy and in-situ vaccination. Dr Saunus has secured more than $6 million in funding and co-authored approximately 70 original research and review articles published in high-impact journals such as Cancer Research, Nature, Science Translational Medicine, Nature Communications, and The Journal of Pathology. She is a proponent of biospecimen banking and clinician and consumer engagement in translational research.
Mater Research Institute-UQ launches $1.9M pilot targeting aggressive breast cancers like TNBC via CDCP1. Explore the science, impacts, and careers in this higher ed breakthrough.